Acta Vet. Brno 2019, 88: 43-47

https://doi.org/10.2754/avb201988010043

Her-2 expression in feline mammary lesions

Lígia Fernandes Gundim1, Taís Meziara Wilson2, Nicolle Pereira Soares1, Igor de Paula Castro1, Mariana Ribeiro Castro1, Alessandra Aparecida Medeiros-Ronchi1

1Federal University of Uberlândia, Animal Pathology Laboratory, Uberlândia, MG, Brazil
2University of Brasília, Animal Pathology Laboratory, Brasília, Brazil

Received May 31, 2018
Accepted February 12, 2019

References

1. Castagnaro M, Casalone C, Bozzetta E, De Maria R, Biolatti B, Caramelli M 1998: Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas. J Comp Path 119: 263-275 <https://doi.org/10.1016/S0021-9975(98)80049-2>
2. Cunha S, Corgozinho K, Justen H, Silva K, Leite J, Ferreira AM. 2016: Survival and disease-free interval of cats with mammary carcinoma treated with chain mastectomy. Acta Sci Vet 44: 1-8
3. De Campos CB, Damasceno KA, Gamba CO, Ribeiro AM, Machado CJ, Lavalle GE, Cassali GD 2015: Evaluation of prognostic factors and survival rates in malignant feline mammary gland neoplasms. J Fel Med Surg 18: 1003-1012 <https://doi.org/10.1177/1098612X15610367>
4. De las Mulas JM, Van Niel M, Millan Y, Blankenstein MA, Van Mil F, Misdorp W 2000. Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domest Anim Endocrinol 18: 111-125 <https://doi.org/10.1016/S0739-7240(99)00067-3>
5. De Maria R, Olivero M, Iussich S, Nakaichi M, Murata T, Biolatti B, Di Renzo MF 2005. Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer. Cancer Res 65: 907-912
6. Dyce M, Sack W, Wensing C 2004. Glândula mamária. Tratado de Anatomia Veterinária. Rio de Janeiro: Elsevier, pp. 357-358
7. Elston EW, Ellis IO 1993. Method for grading breast cancer. J Clin Path 46: 189 <https://doi.org/10.1136/jcp.46.2.189-b>
8. Hayes HM Jr., Milne KL, Mandell CP 1985. Epidemiological features of feline mammary carcinoma. Vet Rec 108: 476-479 <https://doi.org/10.1136/vr.108.22.476>
9. Hayden DW, Johnston SD, Kiang DT, Johnson KH, Barnes DM 1981. Feline mammary hypertrophy/fibroadenoma complex: clinical and hormonal aspects. A J Vet Res 42: 1699-1703
10. Hughes K, Dobson JM 2012. Prognostic histopathological and molecular markers in feline mammary neoplasia. Vet J 194: 19-26 <https://doi.org/10.1016/j.tvjl.2012.05.008>
11. Ito T, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N 1996. Prognosis of malignant mammary tumor in 53 cats. J Vet Med Sci 58: 723-726 <https://doi.org/10.1292/jvms.58.723>
12. Kustritz MVR 2007. Determining the optimal age for gonadectomy of dogs and cats. JAVMA 231: 1665-1675 <https://doi.org/10.2460/javma.231.11.1665>
13. Lana SE, Rutteman GR, Withrow SJ 2007. Tumors of the mammary gland. In: Withrow SJ, Page R, Vail DM (Eds). Small Animal Clinical Oncology. Elsevier, pp. 619-636
14. McNeill CJ, Sorenmo KU, Shofer FS, Gibeon L, Durham AC, Barber LG, Overley B 2009. Evaluation of adjuvant doxorubicin‐based chemotherapy for the treatment of feline mammary carcinoma. J Vet Intern Med 23: 123-129 <https://doi.org/10.1111/j.1939-1676.2008.0244.x>
15. MacEwen EG 1990. Spontaneous tumors in dogs and cats: models for the study of cancer biology and treatment. Cancer Metastasis Rev 9: 125-136 <https://doi.org/10.1007/BF00046339>
16. Maniscalco L, Iussich S, de las Mulas JM, Millán Y, Biolatti B, Sasaki N, De Maria R 2012. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours. Vet J 191: 65-71 <https://doi.org/10.1016/j.tvjl.2010.12.016>
17. Matos AJF, Baptista CS, Gärtner MF, Rutteman GR 2012. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures. Vet J 193: 24-31 <https://doi.org/10.1016/j.tvjl.2011.12.019>
18. Millanta F, Citi S, Della Santa D, Porciani M, Poli A 2006. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers. Breast Cancer Res Treat 98: 115-120 <https://doi.org/10.1007/s10549-005-9138-z>
19. Mills SW, Musil KM, Davies JL, Hendrick S, Duncan C, Jackson ML, Simko E 2015. Prognostic value of histologic grading for feline mammary carcinoma a retrospective survival analysis. Vet Pathol 52: 238-249 <https://doi.org/10.1177/0300985814543198>
20. Misdorp W (Ed.) 1999.ĘHistological classification of mammary tumors of the dog and the cat. Armed Forces Institute of Pathology: American Registry of Pathology: World Health Organization Collaborating Center for Comparative Oncology.
21. Ordás J, Millán Y, Dios R, Reymundo C, de las Mulas JM 2007. Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study. BMC Cancer 7: 179 <https://doi.org/10.1186/1471-2407-7-179>
22. Pérez-Alenza MD, Jiménez Á, Nieto AI, Peña L 2004. First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases. Breast Cancer Res 6: R300 <https://doi.org/10.1186/bcr790>
23. Preziosi R, Sarli G, Benazzi C, Mandrioli L, Marcato PS 2002. Multiparametric survival analysis of histological stage and proliferative activity in feline mammary carcinomas. Res Vet Sci 73: 53-60 <https://doi.org/10.1016/S0034-5288(02)00042-5>
24. Rasotto R, Caliari D, Castagnaro M., Zanetti R, Zappulli V 2011. An immunohistochemical study of HER-2 expression in feline mammary tumours. J Comp Pathol 144: 170-179 <https://doi.org/10.1016/j.jcpa.2010.08.010>
25. Seixas F, Palmeira C, Pires MA, Bento MJ, Lopes C 2011. Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis. Vet J 187: 65-71 <https://doi.org/10.1016/j.tvjl.2009.10.030>
26. Shafiee R, Javanbakht J, Atyabi N, Bahrami A, Kheradmand D, Safaei R, Hosseini E 2013. Comparative value of clinical, cytological, and histopathological features in feline mammary gland tumors; an experimental model for the study of human breast cancer. Diagn Pathol 8: 136 <https://doi.org/10.1186/1746-1596-8-136>
27. Pereira PD, Carvalheira J, Gärtner F 2004. Cell proliferation in feline normal, hyperplastic and neoplastic mammary tissue - an immunohistochemical study. Vet J 168: 180-185 <https://doi.org/10.1016/j.tvjl.2003.10.018>
28. Silva MJCS 2016. Clinical and molecular characterization of feline mammary carcinomas overexpressing HER2 proto-oncogene (FMC-HER2+): new strategies for effective diagnostic and cancer therapy. Doctoral thesis. Universidade de Lisboa, Faculdade de Medicina Veterinária, Lisboa
29. Soares M, Correia J, Carvalho S, Ferreira F 2012. Evaluation of fHER2 expression in feline mammary tumours and its correlation with clinicopathological features (in Portuguese). RPCV 111: 191-198
30. Togni M, Masuda EK, Kommers GD, Fighera RA, Irigoyen LF 2013. A retrospective study of 207 cases of mammary tumours in queens (in Portuguese). Pesq Vet Bras 33: 353-358 <https://doi.org/10.1590/S0100-736X2013000300013>
front cover
  • ISSN 0001-7213 (printed)
  • ISSN 1801-7576 (electronic)

Current issue

Archive